Antibiotic Susceptibility of Salmonella, Shigella and Vibrio Isolated from Diarrhea Patients in Jakarta, Indonesia by Meiyanti, Meiyanti et al.
95
Jurnal Kedokteran dan Kesehatan Indonesia
Indonesian Journal of Medicine and Health
Journal homepage : www.journal.uii.ac.id/index.php/jkki
ABSTRACT
*Corresponding author:meiyanti_suhardi@yahoo.com
ARTICLE INFO
Antibiotic susceptibility of Salmonella, Shigella and Vibrio isolated 
from diarrhea patients  in Jakarta, IndonesiaMeiyanti1, Oktavianus  Ch. Salim2, Elly Herwana1 , Joice V.Kalumpiu1,  Murad Lesmana31Department of  Pharmacology, Faculty of Medicine, Trisakti University2Department of  Public Health, Faculty of Medicine, Trisakti University3Department of Microbiology, Faculty of Medicine, Trisakti University
Keyword:antibiotic resistance , diarrhea patient,Jakarta 
DOI : 10.20885/JKKI.Vol7.Iss3.art4
Background:  The rapid increase of antibiotic resistance among enteric pathogens in developing countries has become a great concern. In Indonesia, Salmonella, Shigella, and Vibro are still an important public health problem. 
Objectives:  The purpose of this  study was to determine the antibiotic resistance patterns of several diarrhea-causing enteric bacteria that are frequently found in Indonesia, particularly Salmonella, Shigella and Vibrio.  
Methods:  A cross-sectional  study was conducted ,  among 150 rectal swabs collected from patients with diarrhea, the enteric pathogens isolated comprised Shigella (11.4%), Salmonella (6.6%) and Vibrio (2.7%). 
Results: Antibiotic susceptibility test  on Shigella species to several antibiotics such as ampicillin, chloramphenicol, tetracycline and , trimethoprim-sulfamethoxazole  showed a considerably high resistance 
rate (25%-100%), whereas ceftriaxone, ciprofloxacin, norfloxacin and nalidixic acid were apparently still effective (resistance rate 0%). Non-typhoid Salmonella had similar resistance  patterns as those of 
Shigella, particularly to ampicillin, tetracycline,  chloramphenicol and trimethoprim- sulfamethoxazole  However, for S. typhi it was found that all antibiotics were still effective. Vibrio was resistant to ampicillin (resistance  rate 100%), whereas the other antibiotics were still effective. 
Conclusion:  It may be concluded that for each of the enteric pathogens the antibiotic resistance pattern should be determined. Use of antibiotics should be based on the antibiotic susceptibility tests.
Latar Belakang:  Peningkatan pesat resistensi antibiotik antara patogen enterik di negara berkembang 
telah menjadi perhatian besar. Di Indonesia, Salmonella, Shigella, dan Vibro masih merupakan 
masalah kesehatan masyarakat yang penting. 
Tujuan:  Tujuan dari penelitian ini adalah untuk menentukan pola resistensi antibiotik dari beberapa 
bakteri enterik penyebab diare yang sering ditemukan di Indonesia, khususnya Salmonella, Shigella 
dan Vibrio. 
Metode:  Sebuah studi cross-sectional dilakukan, antara 150 penyeka dubur yang dikumpulkan dari 
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pasien dengan diare, patogen enterik terisolasi 
terdiri Shigella (11,4%), Salmonella (6,6%) dan 
Vibrio (2,7%). 
Hasil:  Uji kepekaan antibiotik pada spesies 
Shigella beberapa antibiotik seperti ampisilin, 
kloramfenikol, tetrasiklin dan, trimethoprim-
sulfamethoxazole menunjukkan tingkat resistensi 
yang cukup tinggi (25% -100%), sedangkan 
ceftriaxone, ciprofloxacin, norfloksasin dan 
asam nalidiksat yang tampaknya masih efektif 
(resistensi tingkat 0%). Salmonella non-tifoid 
memiliki pola resistensi yang sama seperti orang-
orang dari Shigella, khususnya terhadap ampisilin, 
tetrasiklin, kloramfenikol dan trimethoprim- 
sulfametoksazol Namun, untuk S. typhi ditemukan 
bahwa semua antibiotik masih efektif. Vibrio 
adalah resisten terhadap ampisilin (tingkat 
resistensi 100%), sedangkan antibiotik lain yang 
masih efektif. 
Kesimpulan:  Dapat disimpulkan bahwa untuk 
setiap enterik yang patogen pola resistensi 
antibiotik harus ditentukan. Penggunaan 
antibiotik harus didasarkan pada uji kepekaan 
antibiotik.
INTRODUCTIONAntibiotic treatment against bacterial infections is generally an important factor in reducing the morbidity and mortality rates. However, excessive and incorrect use of antibiotics for the treatment of disease may increase the occurrence of bacterial resistance to these antibiotics.1,2  This results in reduced 
benefits and efficacy of antibiotics commonly used in therapy, thus causing serious problems, such as a longer  course of the infectious disease and unnecessary exposure of the patient to drug toxicity.  Antibiotic resistance may cause inappropriate selection of antibiotics at the start of treatment, as antibiotic administration is done empirically. The results of the treatment are unsatisfactory due to  of the ineffectiveness of the  antibiotic against already resistant bacteria. This problem becomes important because of increased prevalence of resistance againts antibiotic drugs commonly used in the treatment of infectious disease. The development of antibiotic resistance is accelerated by the use of antibiotics in animals 
and their inappropriate use in humans.3 The rapid and continuous occurrence of antibiotic 
resistance in enteric pathogenic bacteria to first-line antibiotics for the treatment of diarrhea has caused various problems and concerns in developing countries.1,4 In developing countries the diarrhea-causing enteric pathogenic bacteria, such as 
Salmonella, Shigella and Vibrio, still constitute an important public health problem.4 Although 
Salmonella infections are self-limiting, i.e. the 
patient recovers after  a time without specific treatment, the disease may be severe and fatal, so that antibiotics are needed. 5-7 In addition, there are reports from various countries of increased resistance rates and the occurrence of multiresistance in Salmonella.8 In cases of infections caused by Shigella, high mortality rates have been reported as well as malnutrition and growth disturbances in children as a result of the disease.9 Shigellosis is related to poor hygiene, poverty and crowded housing. In the last few decades Shigella species have shown changes in antibiotic susceptibility patterns. These bacteria progressively show resistance to various antibiotics primarily used in the treatment of diarrhea.10 They are resistant to conventional antibiotics such as ampicillin, tetracycline, and trimethoprim-sulfamethoxazole  but generally 
are sensitive to fluoroquinolones.9For cholera, antibiotic treatment is important because it may reduce the frequency of diarrhea and the volume of stools excreted by the patient.8 For more than 30 years tetracycline had been the drug of choice for the treatment of cholera. To 
date no significant numbers of Vibrio cholerae resistant to this antibiotic have been found in Indonesia. In contrast, increased resistance rates to several antibiotics have been found in V. parahaemolyticus.9  For patients with diarrhea in developing countries, laboratory investigations, comprising bacterial culture and antibiotic resistance test, are rarely performed, because  of the high cost of the investigations. Patients usually receive antibiotic treatment on the basis of clinical signs and symptoms of 
diarrhea without laboratory confirmation. The purpose of this  study was to determine the antibiotic resistance patterns of several 
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diarrhea-causing enteric bacteria that are frequently found in Indonesia, particularly 
Salmonella, Shigella and Vibrio.  Understanding the antibiotic resistance patterns of these pathogens is important, because it may guide empirical treatment in the framework of reducing inapproriate antibiotic use. 
METHODS Study subjects and location. This study was conducted on patients with diarrhea who attended Community Health Center, South Jakarta,  Indonesia, from  September 2011 until 
May 2013. Diarrhea was defined as three or more loose stools during the previous 24 hours.11 Informed consent and patient information. Before sample collection, signed informed consent for voluntary participation in the study was requested from the patient or  guardian (in case of a child). After obtaining consent, a 
clinical questionnaire was completely filled out by study personel. Information on personal data and the disease of the patient was recorded by health personel appointed for this task, followed by collection of a stool specimen. The data collected from the subjects comprised age, gender, clinical signs and symptoms, and stool samples or rectal swabs for bacterial culture and antibiotic susceptibility testing
Bacteriological procedures
Media. The culture media used in this study consisted of  xylose-lysine-deoxycholate agar (XLD), MacConkey agar (MAC), Salmonella-Shigella agar (SS), and thiosulfate citrate bile salts sucrose agar (TCBS). All media were obtained from DIFCO, Becton Dickinson, Sparks, MD, and prepared according to previously described methods 12,13
Study material and culture process  Rectal swab was collected from patient with diarrhea who attended the Community Health Center. The sample was taken irrespective of disease severity (mild, moderate, or severe). Rectal swab was collected at the time of attendance and before administration of antibiotics. Care was taken to collect the swab before the fourth day of illness, since after 
four days the bacterial population would have decreased, presumably resulting in a false negative.  Rectal swab was placed in Cary Blair transport medium and stored in a refrigerator until transported to the laboratory. The samples were transported under cold conditions by placing them in a thermos bottle. On arrival at the laboratory the rectal swabs were plated onto MAC, SS, XLD and TCBS.  The agar plates were incubated aerobically at 37°C for 18-24 hours.  Suspected  colonies were picked and 
grown in biochemical media for identification and characterization.12,13  Serological tests for 
confirmation were done on each bacterial 
species isolated  using specific antiserum (DIFCO, Becton Dickinson, Sparks, MD).
Antibiotic susceptibility testing Bacterial isolates were subsequently subjected to antibiotic susceptibility testing against ampicillin (Am), chloramphenicol (C), tetracycline (Te), trimethoprim sulfamethoxazole 
(Sxt), ceftriaxone (Cro), ciprofloxacin (Cip), 
norfloxacin (Nor) and nalidixic  acid (Na), The test was performed using the disk diffusion method in accordance  with the guidelines of Clinical and Laboratoy Standards Institute.14  The antibiotic disks used in this  test were obtained from Becton Dickinson and Company, Cockeysville, MA, USA. 
Escherichia coli ATCC 25922 and Staphylococcus 
aureus ATCC 25923 were included  in the test as control strains.  The test result was read by measuring the inhibition zone demonstrated by the culture.  Determination of sensitive, resistant or  intermediate was in accordance with established standards. 14
RESULTSOverall, 150 rectal swab specimens were collected from patients with diarrhea of all ages without regard to disease severity.  From these rectal swabs the isolated enteric pathogenic bacteria consisted of Shigella (11.4%), Salmonella (6.6%) and  Vibrio (2.7%) species. Shigella strains isolated were S. dysenteriae (0.7%), S. 
flexneri (6.7%), S. sonnei (2.7%) and S. boydii (1.3%). Salmonella sp  isolated consisted of non-typhoid Salmonella and S. typhi, with percentages of 5.3% and 1.3%, respectively. The remaining 
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isolates were species of Vibrio, namely Vibrio non-O1 (2.0%) and V. parahaemolyticus (0.7%) (Table 1).Results of suceptibility test showed variable resistance  among the various bacterial isolates. Of the Shigella species, S. flexneri showed the highest resistance rate (80%-90%) to ampicillin, chloramphenicol, tetracycline and trimethoprim-sulfamethoxazole. S. sonnei and S. boydii were mostly resistant to tetracycline and trimethoprim-sulfamethoxazole (75%-100%), while all S. dysenteriae  tested (100%) showed resistance to chloramphenicol and trimethoprim-sulfamethoxazole (Table 1). For non-typhoid Salmonella, resistance to ampicillin and tetracycline comprised more than half (62.5%) of the isolates, however many were still sensitive to chloramphenicol and trimethoprim-sulfamethoxazole (75% and 87.5%, respectively). For S.typhi no isolates were encountered that were resistant to the antibiotics tested. Vibrio cholera was not found in this study, but of the 
Vibrio non-O1 and V. parahaemolyticus that were isolated, all were resistant to ampicillin (100%) but sensitive to the other antibiotics.
DISCUSSIONResistance to antibiotics may result in changes in virulence of  microorganisms and poor response to empirical antibiotic treatment, because the microorganisms are already resistant to the antibiotic in question. Infections caused by antibiotic-resistant microorganisms tend to lead to a longer or a more severe course of the disease, in comparison with infections by bacteria that are still sensitive to antibiotics. In recent years an increased incidence of infections have been reported, and also multiantibiotic resistance  by non-typhoid 
Salmonella. 15,16 They stated on the basis of their study results that of all isolated non-typhoid 
Salmonella serotypes, S. Newport was the most resistant to tetracycline, although it was still sensitive to the other antibiotics tested. The majority of the multiresistant serotypes were 
S. Typhimurium  and S. Hadar. Overall, among the isolated and tested non-typhoid Salmonella species in the study of Bukitwetan et al16 many were multiresistant, as had also been reported 
by other investigators.15  In our study,  the non-typhoid Salmonella species obtained were on 
average resistant to four first-line antibiotics that are commonly used in therapy and 20% of these were even resistant to nalidixic acid (Table 1).  However, only a small percentage of the non-typhoid Salmonella were resistant to chloramphenicol, an antibiotic that had previously been the drug of choice for  Salmonella infections, particularly S. typhi.  
S. typhi species which we isolated did not show resistance to the eight antibiotics tested, as they were sensitive to all. However, because of the extremely small number of isolates that we obtained, viz. only two (1.3%), this does  not constitute a general picture of the antibiotic sensitivity status of  S. typhi in Jakarta. On the other hand, the report of Ochiai et al17  stated that in Indonesia, with an S. typhi isolation rate of 3.31%, no antibiotic-resistant S. typhi was found, as is  the case with China. This situation is very different from that of S. typhi from Vietnam, Pakistan, and India, where many S. typhi isolates are already resistant to antibiotics, and even show multidrug resistance (MDR), i.e. to ampicillin, chloramphenicol and trimethropim-sulfamethoxazole, the percentages being 7% in India and up to 65% in Pakistan17. The presence of MDR  accompanied by resistance 
to fluoroquinolones and nalidixic acid, which is developing rapidly in Vietnam,  results in 
problems and difficulties in the treatment of typhoid fever. In 2004 it was reported that isolates of S. typhi in Vietnam, which in the 
previous five years had a resistance rate of 87% to nalidixic acid, in that year had a resistance rate of up to 97% 18. Patients with S. typhi infections resistant to nalidixic acid show a poor clinical response with a therapeutic failure rate of up to 36% accompanied by a prolonged fecal carrier state.  Although in South Vietnam MDR in S. typhi has been reportedly high in the last 13 years or more, there are reports that in other regions isolates of S. typhi are encountered that are again sensitive to chloramphenicol, although in general in other Asian countries the MDR rate of S. typhi is still high. 17-19 During the last few years no cholera epidemic has been reported in Indonesia and 
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the prevalence of cholera is not high, namely around 3%. In spite of that, cholera, which causes acute diarrhea, is still considered to be a health 
hazard in the under-fives, particularly babies younger than 1 year of age 20 . In our present study no V. cholerae O1 was found. This may have been due to an inadequate sample size that did not allow the isolation of V. cholerae O1, whose current incidence tends to be low, namely only 0.5/1000/year  20. Other isolated 
Vibrio species were V. cholerae non-O1 (2.0%) and V. parahaemolyticus (0.7%). Both Vibrio species are in general still sensitive to all tested antibiotics, except ampicillin, to which they were fully resistant (100%). Agtini et al20 reported that in a survey conducted in Jakarta, >90% of isolates of V. cholerae O1 were still sensitive to trimethoprim-sulfamethoxazole, tetracycline, 
and chloramphenicol, besides fluoroquinolones. However, although  they successfully isolated non-cholera bacteria, Agtini et al 20 in their reports did not mention the antibiotic sensitivity patterns of these bacterial species. Antibiotic resistance of V. cholerae non-O1 and V. parahaemolyticus was reported by Tjaniadi et al 21. It was stated that antibiotic resistance in V. cholerae non-O1 was from year to year clearly increasing in frequency with regard to antibiotics commonly used in the treatment of diarrhea in Indonesia. According to the report 21, V. parahaemolyticus also showed an increasing frequency of antibiotic resistance, although its pattern was slightly different from that found in V. cholerae non-O1. 
V. parahaemolyticus was still sensitive to most of the antibiotics, except for a few number (3-15%) that were resistant to tetracycline and chloramphenicol, while to ampicillin all isolates (100%) were already resistant. This situation is similar to that found in our study, so that it may be stated that in the last 10 years there have not been many changes in the antibiotic susceptibility pattern of V. parahaemolyticus.
Shigella is the main cause of diarrhea leading to high mortality in developing countries and consistently associated with the syndrome of clinical dysentery, prolonged diarrheal episodes and persistent diarrhea.9 Episodes of dysentery are also a risk factor for malnutrition and growth disturbances in children. Antibiotic resistance 
of these bacteria is developing progressively in Asian, African and Latin American countries.9 The study of Kosek et al 9 reported that overall the isolates of  Shigella  obtained (63%-83%) were already resistant to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, tetracycline and erythromycin, but were in general still sensitive to quinolones and ceftriaxon. Similar antibiotic resistance patterns of Shigella have also been reported by other investigators.21-23In our study, among the isolates of Shigella that we obtained and of which we tested the antibiotic sensitivity, all showed resistance to the main antibiotics, i.e. ampicillin, chloramphenicol, tetracycline and trimethoprim-sulfamethoxazole. However, different serotypes had different sensitivity patterns. All Shigella serotypes were already resistant to trimethoprim-sulfamethoxazole except for 
S. flexneri (90% resistant), the other serotypes, namely S. dysenteriae, S, boydii and S. sonnei, were all (100%) resistant to trimethoprim-sulfamethoxazole (Table 1). Of the four serotypes that could be isolated, S. flexneri and S. sonnei showed multi-antibiotic resistance, namely to ampicillin, chloramphenicol, tetracycline and trimethoprim-sulfamethoxazole. To other 
antibiotics such as the quinolones ciprofloxacin, 
norfloxacin, nalidixic acid, and also to ceftriaxone, all Shigella isolates were still sensitive.  The survey conducted by Agtini et al20 in North Jakarta reported that more than 73% isolates of 
S. flexneri  were resistant to  the four antibiotics as in our  study.  Apparently during the last few years there have not been many changes in the antibiotic sensitivity patterns of S. flexneri and other Shigella species in Jakarta. Because of the high frequency of antibiotic resistance  of  Shigella species to those four antibiotics, they cannot be used anymore for the treatment of shigellosis. Although there are recommendations to give antibiotic treatment to shigellosis in children, the main concern is the selection of antibiotics to be given in the treatment, in view of the great number of resistant Shigella species. The use of 
fluoroquinolones in children with shigellosis is still controversial, and therefore alternative drugs should be looked for.  According to the report of Herwana et al 24 and our own study 
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results, no resistance of Shigella to nalidixic acid has been found, so that nalidixic acid is currently the antibiotic of choice in the treatment of shigellosis in children in Jakarta or even in Indonesia. Except for various reports on the resistance of Shigella species, from our study 
results it is difficult to come to a conclusion about the antibiotics susceptibility of  S. dysenteriae and 
S. boydii, because of the small numbers of isolates that we obtained. For Vibrio species there are not many problems in antibiotic treatment, however those antibiotics that a few years ago were in common use for the treatment of shigellosis 
and salmonellosis, are currently of no benefit, because of the high frequency of resistance in these bacteria.  Although the mechanisms of resistance in organisms have been clearly known, including selective pressure as a result of exposure to antibiotics, the precise role of drug usage in the selection of antibiotic resistance cannot be fully explained yet. Therefore, it is recommended to be careful in the use of antibiotics for the treatment of infectious disease.
CONCLUSION  For each of the enteric pathogens the antibiotic resistance pattern should be determined.  Understanding the antibiotic resistance patterns of these pathogens is important, because it may guide empirical treatment in the framework of reducing inapproriate antibiotic use.  Use  of antibiotics should be based on the antibiotic susceptibility tests.
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